Cargando…

The Mitochondrion: A Promising Target for Kidney Disease

Mitochondrial dysfunction is important in the pathogenesis of various kidney diseases and the mitochondria potentially serve as therapeutic targets necessitating further investigation. Alterations in mitochondrial biogenesis, imbalance between fusion and fission processes leading to mitochondrial fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanriover, Cem, Copur, Sidar, Ucku, Duygu, Cakir, Ahmet B., Hasbal, Nuri B., Soler, Maria Jose, Kanbay, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960839/ https://www.ncbi.nlm.nih.gov/pubmed/36839892 http://dx.doi.org/10.3390/pharmaceutics15020570

Ejemplares similares

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival
por: Kanbay, Mehmet, et al.
Publicado: (2022)

A new immune disease: systemic hypertension
por: Copur, Sidar, et al.
Publicado: (2023)

Novel strategies in nephrology: what to expect from the future?
por: Copur, Sidar, et al.
Publicado: (2022)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

Intravenous fluid therapy in accordance with kidney injury risk: when to prescribe what volume of which solution
por: Kanbay, Mehmet, et al.
Publicado: (2022)

The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

Post-acute COVID-19 syndrome and kidney diseases: what do we know?
por: Copur, Sidar, et al.
Publicado: (2022)

Is the mitochondrion a promising drug target in trypanosomatids?
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2022)

A primer on metabolic memory: why existing diabesity treatments fail
por: Copur, Sidar, et al.
Publicado: (2020)

Acute kidney injury in hospitalized COVID-19 patients
por: Kanbay, Mehmet, et al.
Publicado: (2021)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems
por: Wen, Ru, et al.
Publicado: (2016)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence
por: Kalay, Zeynepgul, et al.
Publicado: (2022)

Of mitochondrion and COVID-19
por: Alfarouk, Khalid Omer, et al.
Publicado: (2021)

Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021)

Determinants of Pancreatic Steatosis: A Retrospective Observational Study
por: Altinmakas, Emre, et al.
Publicado: (2021)

Is myelin a mitochondrion?
por: Harris, Julia J, et al.
Publicado: (2013)

Mitochondrion as a Target of Astaxanthin Therapy in Heart Failure
por: Krestinina, Olga, et al.
Publicado: (2021)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

HIV and Apoptosis: Death and the Mitochondrion
por: Basañez, Gorka, et al.
Publicado: (2001)

Role of the Mitochondrion in Programmed Necrosis
por: Baines, Christopher P.
Publicado: (2010)

What makes a mitochondrion?
por: Heazlewood, Joshua L, et al.
Publicado: (2003)

The quantum mitochondrion and optimal health
por: Nunn, Alistair V.W., et al.
Publicado: (2016)

Foreign Plastid Sequences in Plant Mitochondria are Frequently Acquired Via Mitochondrion-to-Mitochondrion Horizontal Transfer
por: Gandini, C. L., et al.
Publicado: (2017)

A mitochondrion-free eukaryote contains proteins capable of import into an exogenous mitochondrion-related organelle
por: Fang, Yi-Kai, et al.
Publicado: (2023)

Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy
por: Mahalingam, Sakkarapalayam M., et al.
Publicado: (2018)

Fetal Cerebral Artery Mitochondrion as Target of Prenatal Alcohol Exposure
por: Bukiya, Anna N.
Publicado: (2019)

Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?
por: Gungor, Ozkan, et al.
Publicado: (2021)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Air pollution and kidney disease: review of current evidence
por: Afsar, Baris, et al.
Publicado: (2018)

Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases
por: Chernega, Timofei, et al.
Publicado: (2022)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
por: Lucini, Chantal B., et al.
Publicado: (2021)

Molecular characterization, targeting and expression analysis of chloroplast and mitochondrion protein import components in Nicotiana benthamiana
por: Sáiz-Bonilla, María, et al.
Publicado: (2022)

Dual Targeting of Antioxidant and Metabolic Enzymes to the Mitochondrion and the Apicoplast of Toxoplasma gondii
por: Pino, Paco, et al.
Publicado: (2007)

Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery
por: Jiang, Lei, et al.
Publicado: (2021)

Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction
por: Wang, Han, et al.
Publicado: (2022)

Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review
por: Qin, Yulin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qrk6silgbrrfb4p9sevi03hrf0